Biotech Investment Becomes New Front In US-China Trade Fight
· Business · Politico, Bloomberg
Biotechnology investment has emerged as a central arena in the ongoing trade dispute between the United States and China. Policymakers in Washington and Beijing are scrutinizing cross-border capital flows in life sciences. The sector joins technology and semiconductors as a point of economic rivalry.
Why it matters
Stricter investment screening impacts biotech funding, venture capital, and cross-border research partnerships between the two nations.
Read the original report — Politico
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.